Abstract: Keywords: New York City; State:New York; United States; North and Central America; Antigens; B-Cell Lymphoma; B-Cell Receptors; B-Lymphocyte Antigens; Biological Factors; Biological Therapy; Biomedical Engineering; Biomedicine; Biotechnology; Blood Proteins; CD Antigens; CD19 Antigens; Cancer; Cell Therapy; Drugs and Therapies; Health and Medicine; Hematology; Immunoglobulins; Immunology; Immunoproliferative Disorders; Large B-Cell Lymphoma; Lymphatic Diseases and Conditions; Lymphoma; Lymphoproliferative Disorders; Oncology; Proteins EN New York City State:New York United States North and Central America Antigens B-Cell Lymphoma B-Cell Receptors B-Lymphocyte Antigens Biological Factors Biological Therapy Biomedical Engineering Biomedicine Biotechnology Blood Proteins CD Antigens CD19 Antigens Cancer Cell Therapy Drugs and Therapies Health and Medicine Hematology Immunoglobulins Immunology Immunoproliferative Disorders Large B-Cell Lymphoma Lymphatic Diseases and Conditions Lymphoma Lymphoproliferative Disorders Oncology Proteins 936 936 1 07/10/23 20230711 NES 230711 2023 JUL 10 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Investigators discuss new findings in Oncology - B-Cell Lymphoma. New York City, State:New York, United States, North and Central America, Antigens, B-Cell Receptors, B-Lymphocyte Antigens, Biological Factors, Biological Therapy, Biomedical Engineering, Biomedicine, Biotechnology, Blood Proteins, CD Antigens, CD19 Antigens, Cancer, Cell Therapy, Drugs and Therapies, Health and Medicine, Hematology, Immunoglobulins, Immunology, Immunoproliferative Disorders, Large B-Cell Lymphoma, B-Cell Lymphoma, Lymphatic Diseases and Conditions, Lymphoma, Lymphoproliferative Disorders, Oncology, Proteins. [Extracted from the article]
No Comments.